press release
EMBL welcomes NetApp in its Corporate Partner Programme
EMBL welcomes NetApp, a leader in cloud data services empowering global organisations to change their world with data, as member of the Corporate Partnership Programme of the EMBL Advanced Training Centre.
DNA damage and faulty repair jointly cause mutations
DNA mutations are caused by a combination of DNA damage and repair, shows study by EMBL-EBI and collaborators.
Nordic EMBL Partnership awarded €210,000 funding
The Nordic EMBL Partnership for Molecular Medicine has been awarded 210,000 euros. The funds will be used to train the next generation of specialists and research leaders in molecular medicine in the Nordic countries.
Unprecedented single-cell studies in virtual embryo
Researchers from EMBL Heidelberg have created a complete description of early embryo development, accounting for every single cell in the embryo.
Understanding brain tumours in children
The causes of 40 percent of all cases of certain medulloblastoma – dangerous brain tumours affecting children – are hereditary. These are the findings of a recent genetic analysis carried out by scientists from EMBL and numerous colleagues around the world.
€2.45 m to investigate leukaemia causes and therapies
The Heidelberg-based LeukoSyStem consortium investigates leukaemia stem cells in acute myeloid leukaemia. The German Federal Ministry of Education and Research financially supports this collaboration between Heidelberg University Hospital, HI-STEM gGmbH, the German Cancer Research Center and EMBL.
New technique for studying living fly larvae
This technique provides a simple but effective way to study the functions of organs in living animals
How females shut off their second X chromosome
Scientists provide important new insights into the molecular basis of X-inactivation
The Pan-Cancer project
EMBL co-leads most comprehensive study of genetic causes of cancer
Melting reveals drug targets in a living organism
EMBL scientists identify drug targets in blood and organs
